- Home
- ZK vs MRUS Comparison
ZK vs MRUS Comparison
Compare ZK & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZK
- MRUS
- Stock Information
- Founded
- ZK 2017
- MRUS 2003
- Country
- ZK China
- MRUS Netherlands
- Employees
- ZK N/A
- MRUS 260
- Industry
- ZK
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- ZK
- MRUS Health Care
- Exchange
- ZK NYSE
- MRUS Nasdaq
- Market Cap
- ZK 5.0B
- MRUS 4.1B
- IPO Year
- ZK 2024
- MRUS 2016
- Fundamental
- Price
- ZK $25.99
- MRUS $53.11
- Analyst Decision
- ZK Strong Buy
- MRUS Strong Buy
- Analyst Count
- ZK 3
- MRUS 12
- Target Price
- ZK $32.13
- MRUS $87.92
- AVG Volume (30 Days)
- ZK 448.2K
- MRUS 2.0M
- Earning Date
- ZK 05-15-2025
- MRUS 07-31-2025
- Dividend Yield
- ZK N/A
- MRUS N/A
- EPS Growth
- ZK N/A
- MRUS N/A
- EPS
- ZK N/A
- MRUS N/A
- Revenue
- ZK $10,494,129,543.00
- MRUS $54,732,000.00
- Revenue This Year
- ZK N/A
- MRUS $75.57
- Revenue Next Year
- ZK $28.16
- MRUS $31.84
- P/E Ratio
- ZK N/A
- MRUS N/A
- Revenue Growth
- ZK 17.46
- MRUS 42.77
- 52 Week Low
- ZK $13.00
- MRUS $33.19
- 52 Week High
- ZK $33.32
- MRUS $62.98
- Technical
- Relative Strength Index (RSI)
- ZK N/A
- MRUS 53.18
- Support Level
- ZK N/A
- MRUS $52.41
- Resistance Level
- ZK N/A
- MRUS $54.59
- Average True Range (ATR)
- ZK 0.00
- MRUS 2.15
- MACD
- ZK 0.00
- MRUS -0.77
- Stochastic Oscillator
- ZK 0.00
- MRUS 7.62
About ZK ZEEKR INTELLIGENT TECHNOLOGY HLDG L SPON ADS EA REP 10 ORD SHS
ZEEKR Intelligent Technology Holding Ltd is a fast-growing BEV technology company. By developing and offering next-generation premium BEVs and technology-driven solutions, It aspires to lead the automobile industry's electrification, intelligentization and innovation. Since its inception, It has focused on innovation in BEV architecture, hardware, software, and application of new technologies. It is principally engaged in the commercialization and sales of electric vehicles and batteries, and the provision of automotive-related research and development services.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.